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Obesity is now a global phenomena. The term 
Globesity and Diabesity is now frequently used to 
denominate the sheer impact it has around the world. It 
is estimated that around 600 million and accounting to 
13% of the world’s population are in the obese 
category and it is predicted that the incidence of 
diabetes would increased by 22% and 69%  in the 
developed and developing countries respectively in the 
next 2 decades  (1). The current obesity phenomena 
has a significant impact on the health related issue 
such as risk of premature death and complications in 
particular metabolic syndrome (2). Uncontrolled 
Diabetes Mellitus may result in serious microvascular, 
macrovascular complications and premature deaths, 
which can be significantly reversed even by a 1% drop 
of HBA1c (3). Currently, the stepwise management of 
obesity are dietary modification, exercise and 
pharmacotherapy (4). However, the outcome of 
conservative treatment are poor in the long term, and 
therefore, surgery would be the best option, resulting 
in a significant, sustainable weight loss, improvement 
of quality of life and potentially reversal of co-
morbidities, in particular its  metabolic components 
(4,5). Currently, the indication for surgery are BMI 
(Body Mass Index) of more than 40 without co-
morbidities and  BMI of more than 35 in patients with 
co-morbidities which has been adopted since the early 
1990s. However, the adequacy of BMI as a stand-
alone criteria for surgery is highly contentious as BMI 
does not always predict the benefits from surgery in 
respect to metabolic, cardio-vascular and mortality (6). 
Furthermore, there are significant differences in the 
metabolic risk in obese populations governed by 
geographical and race distribution, particularly in 
Asian population, where the risk of visceral fat 
accumulation is higher in comparison to its Caucasian 
counterpart and thus increasing the risk of diabetes and 
other metabolic illness (7). The International 
Federation of Surgery for obesity-Asia Pacific chapter, 
released a consensus statement in 2011 agreeing that 
the indications for surgery be changed in light of the 
higher risk in obese Asian patients resulting the  goal 
post being lowered, where the accepted indication for 
bariatric surgery are BMI of 37.5 without co-
morbidities, BMI of 32.5 with co-morbidities and in 
exceptional circumstances where exhaustive 
conservative and medical treatment has failed, surgery 
for BMI of 30 and above can be offered (8). Since the 
inception of bariatric surgery in the late 1950s, the 
technique and type of surgery has revolutionised 
tremendously. There are many different variants of 
bariatric surgery which is categorized as purely 
restrictive such as gastric band, gastric plication and 
sleeve gastrectomy; combined restrictive and 
malabsorptive such as gastric bypass and finally the 
pure malabsorptive procedures such as Biliopancreatic 
diversion and Duodenal switch. Over the past 10 years 
modification to these established procedures has been 
developed such as the minigastric bypass, single 
anastomsis duodenal jejunal bypass with sleeve 
gastrectomy and ileal interposition. The idea of these 
modifications is to reduce the side-effect profile with 
optimum weight loss and enhance the amelioration of 
diabetes and other metabolic derangement. 
The definition of bariatric surgery and metabolic 
surgery has been interchangeable overtime. It has been 
accepted that bariatric surgery is considered when the 
aim of weight reduction take precedent, whereas 
metabolic surgery is considered when the aim is 
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primarily to improve co-morbidities in particular, 
metabolic diseases in addition to weight loss. The 
difficulty in separating both of these terms lead to the 
more appropriate term of Bariatric-Metabolic Surgery 
(BMS). One of the compelling example that  both 
surgery works hand in hand is shown in the study by 
Booth et al., which surgery in a non-diabetic obese 
population followed up to 7 years results in an 80% 
risk reduction of developing diabetes mellitus 
compared to conservative treatment (9).  
There are many compelling level one evidence that 
support the advantages of BMS especially in patients 
with BMI of more than 35 (5), however as the goal 
post for surgery in the Asian population has been 
reduced to below BMI of 35, the need for clinical 
evidence to justify the lowered indication is 
paramount. To date there are at least 7 level one 
randomised controlled trials and several other level 2 
and 3 evidence that support the efficacy and safety of 
BMS in BMI (30-35 kg/m
2
) (10). 
BMS will continue to evolve with time as the 
incidence of obesity and diabetes continues to rise 
despite the advancement of medical treatment. It is 
essential that the global management for these patients 
are dealt in a multi-disciplinary manner involving 
surgeon, endocrinologist, dietician, physiotherapist, 
specialist physician and psychologist to name a few. 
Rigorous pre-operative work-up and ultimately the 
right patient selection is vital in order to have the best 
post operative outcome in particular in long-term 
durable weight lost and most importantly the 
resolution of co-morbidities.   
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